Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Aselage Steve
Relationship:   Director
City:   Fremont
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   293,421    

Indirect Shares

   22,000      
Direct Value   $6,950,507    

Indirect Value

   $160,840      
Total Shares   315,421      
Total Value   $7,111,347      


Cti Biopharma Corporation $219,369 Biomarin Pharmaceutical Inc $5,231,829 Travere Therapeutics, Inc $1,090,139 Biocryst Pharmaceuticals Inc $409,170 Cti Biopharma Corporation $219,369 Biomarin Pharmaceutical Inc $5,231,829 Travere Therapeutics, Inc $1,090,139 Biocryst Pharmaceuticals Inc $409,170
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    5   
    5    

     Stock price went up :
    1   
    3    
     Stock price went down :
    4   
    2    
   
     Gain/Loss Ratio :
   0.0   
   1.5   
     Percentage Gain/Loss :
   -23.4%
 62.9%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Cti Biopharma Corporation CTIC EVP, Global Commercial... 2005-06-30 24,133 2004-08-03 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN EVP, Chief Business Of... 2012-07-02 59,030 2006-04-28 0    Premium*  
            Travere Therapeutics, Inc TVTX Director 2022-05-11 146,919 2021-11-05 19,500    Premium*  
            Acer Therapeutics Inc ACER Director 2023-11-17 0 2017-09-19 0    Premium*  
            Biocryst Pharmaceuticals Inc BCRX Director 2024-05-24 63,339 2024-05-24 2,500    Premium*  
* Premium Members only  

Records found :    170         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2019-12-01 4 A $2.85 $4,999 D/D 1,754 23,426 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-08-31 4 A $15.92 $4,999 D/D 314 32,444 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2022-02-28 4 A $16.61 $5,000 D/D 301 33,159 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2022-05-31 4 A $9.31 $5,297 D/D 569 33,728 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2008-04-01 4 OE $7.16 $5,764 D/D 805 32,839 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Ops   •       –      –    2006-04-28 4 A $6.92 $6,635 D/D 959 959 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-11-17 4 OE $14.39 $7,195 D/D 500 30,381 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-02-26 4 A $10.78 $9,993 D/D 927 31,496 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2020-11-30 4 A $5.11 $9,995 D/D 1,956 30,569 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2020-08-31 4 A $4.15 $9,997 D/D 2,409 28,613 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-05-28 4 A $15.77 $9,998 D/D 634 32,130 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2014-11-20 4 B $8.20 $10,660 D/D 1,300 363,056 2.81 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2019-05-22 4 B $3.57 $10,710 D/D 3,000 5,000 2.39 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-11-17 4 S $25.80 $12,900 D/D (500) 61,256 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Ops   •       –      –    2006-10-31 4 B $6.92 $12,939 D/D 1,870 2,829 2.74 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2007-04-30 4 B $6.92 $14,295 D/D 2,066 4,895 2.74 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2007-10-31 4 AB $6.92 $14,800 D/D 2,139 7,034 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev.   •       –      –    2008-04-30 4 B $10.37 $15,825 D/D 1,526 33,560 2.74 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2024-05-24 4 B $6.40 $16,000 I/I 2,500 2,500 2.1 %
ACER Acer Therapeutics Inc Director   –       •      –    2021-12-10 4 B $2.04 $16,287 D/D 7,984 73,905 2.39 %
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2008-10-31 5 B $13.35 $16,506 D/D 1,236 32,401 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2009-04-30 4 A $10.93 $16,560 D/D 1,515 33,916 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2019-03-12 4 B $8.30 $16,600 D/D 2,000 2,000 2.39 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2020-05-12 4 AS $17.16 $17,160 D/D (1,000) 252,857 0 %
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-04-30 4 A $11.64 $17,827 D/D 1,532 21,387 0 -
  170  Records found
  1   2   3  4   5   6   7      
  Page 3 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us